Form 990 for tax year 2022
Filed by ARMS WIDE OPEN CHILDHOOD CANCER FOUNDATION.
Totals
- Total revenue
- $2,099,962
- Total expenses
- $1,706,444
- Contributions and grants received
- $1,373,326
- Grants paid
- $1,053,063
- Program services expenses (Part IX)
- $1,302,446
- Management and general expenses
- $101,587
- Fundraising expenses
- $302,411
- Program service expenses (Part III)
- $1,302,446
Program services were 76.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Listed in Part VII
-
WILLIAM SHERWOOD
TRUSTEE, VICE PRESIDENT
- Total calculated
- $0
- Hours/week
- 5
-
LINDA TARANTO
SECRETARY
- Total calculated
- $0
- Hours/week
- 5
-
JAMES BEALE
TRUSTEE
- Total calculated
- $0
- Hours/week
- 10
-
KRISTEN ALEXANDER
TREASURER
- Total calculated
- $0
- Hours/week
- 30
-
AMANDA BOWEN
TRUSTEE
- Total calculated
- $0
- Hours/week
- 5
-
CHRISTINA MCGRATH
TRUSTEE
- Total calculated
- $0
- Hours/week
- 5
-
MIKE GILLETTE
OFFICER
- Total calculated
- $105,464
- From this org
- $105,464
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $105,464
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $105,464
-
DENA SHERWOOD
CHAIR, BD OF TRUSTEE
- Total calculated
- $107,498
- From this org
- $107,498
- From related orgs
- $0
- Other
- $0
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $107,498
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $107,498
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
UCSF PEDIATRIC NUERO ONCOLOGY
$170,236
TO ASSIST WITH CANCER RESEARCH
-
MEMORIAL SLOAN KETTERING CANCER CENTER
$155,000
FUNDIING ANTI-NB VACCINE TRIAL
-
TO ASSIST WITH CANCER RESEARCH- COLLABORATIVE PEADIATRIC CANCER RESEARCH AWARDS PROGRAM
-
$110,178
TO ASSIST WITH CANCER RESEARCH
-
$99,996
PEDIATRIC CANCER IMMUNOTHERAPY RESEARCH
-
PEDIATRIC CANCER IMMUNOTHERAPY RESEARCHPEDIATRIC CANCER IMMUNOTHERAPY RESEARCHPEDIATRIC CANCER IMMUNOTHERAPY RESEARCH
-
$25,000
TO ASSIST WIHT CANCER RESEARCH
-
CHILDREN'S HOSPITAL OF PHILADELPHIA FOUNDATION
$24,000
RESEARCH FUNDING
-
CHILDREN'S HEALTHCARE OF ATLANTA
$10,185
RESEARCH FUNDING
-
$10,000
TO ASSIST WITH CANCER RESEARCH
The 10 largest by cash amount. The API serves every itemized grant.
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 7 June 2023
- IRS schema version
- 2022v5.0
- Source object
- 202341599349300304
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.